Baxter Ventures has participated in a series D round for Outset Medical, a spinout of Oregon State University.

Aptus-backed Alzheon hopes to raise $40.3m in proceeds, less than half as much as it had targeted earlier this year before withdrawing plans in May.

Advocate Aurora Health, Foxconn, Johnson Controls and Northwestern Mutual have each put $25m into a $100m venture capital fund.

Baxter Ventures has participated in a series D round for Outset Medical that was led by Mubadala Investment Company.

Nanovis, a spinal implant nanotechnology developer, has been backed by Elevate Purdue Foundry Fund, which joins existing investors including Apex One Equity Fund.

The size of the deal for portfolio company NxThera could reach $406m in size, with Mitsui exiting the medical device maker through the acquisition.

Matarki Bioscience has been spun out under a drug discovery model to carry Warsaw pharmaceutical research through pre-clinical and early clinical trials.

The Lilly Ventures, GV and Bluebird Bio-backed cancer immunotherapy developer has raised at least $188m in the past three years.